The Medical Services Advisory Committee (MSAC) has given a positive recommendation to Kymriah a CAR T-cell therapy to treat refractory or relapsed diffuse large B-cell lymphoma (DLBCL), follicular lymphoma (FL) including transformed, and primary mediastinal B-cell lymphoma (PMBCL). The treatment would cost an individual up to $500,000 but will now be funded by the government. In more good news, Peter MacCallum Cancer Centre will be one of the few places in...
making hope real for australians
in the fight against blood cancers
You have a blood cancer
Five little life-changing words that over 15,000 Australian men, women and little children will be told this year.
One day, we hope no one ever has to hear those five little words again.
Focus on new blood cancer treatment
Right now, cancer research is rapidly growing with the support and introduction of new technology into human genes. Just imagine a treatment that is tailored or personalised to match your type of cancer as well as your personal genetic profile. Well, it’s not a distant dream and it is certainly no research black hole as...
Read MoreAchievements
View achievementsAnnual reports
View reportsPatient stories
View storiesSnowdome's unique approach
Read our approachWhat is blood cancer?
Blood cancers are common genetic diseases, but not in the sense that they're conditions you inherit from your parents. Rather, blood cancers are caused by the genes.
Read More372
Patients
have gained access to new treatments with Snowdome support
20
Clinical Trials
have commenced with Snowdome infrastructure support
$25
Million
secured and directed to Snowdome prioritized projects
Snowdome in the news
-
-
Professor Ricky Johnstone is the Head of the Gene Regulation Laboratory at the Peter MacCallum Cancer Centre and the Head, The Sir Peter MacCallum...
-
We are deeply saddened to hear the news of Tom Long passing. Tom was an inspiration to many. He bravely shared his journey with...
